NASDAQ:APRE

Aprea Therapeutics Stock News

etoro logo Buy APRE
*Your capital is at risk
$0.762
-0.0022 (-0.288%)
At Close: Jun 03, 2026
Aprea Therapeutics (APRE) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
These companies offer promising pipelines that could deliver in the long term.
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Aprea Therapeutics Inc., (APRE), a clinical-stage biotechnology company focused on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein, today a
SEBI regulations already permit REIT, InvITs' debt issuance to foreign portfolio investors. Finance Minister Nirmala Sitharaman, in Union Budget 2019, had already allowed foreign portfolio investors (
ZenWTR expects to keep up to 70 million PET water bottles from reaching the ocean in 2020.
The Consumer Financial Protection Bureau plans to change the definition of what constitutes a qualified mortgage from a 43% debt-to-income limit to a price-based threshold, and further extend a tempor

How To Get A Mortgage: 7 Steps To Success

05:03pm, Monday, 22'nd Jun 2020
Buying a home is one of the most exciting things you’ll do in your life. It’s also likely the most expensive. Unless you have a swimming pool full of cash, you’ll need to take out a mortgage to
If you’re looking to pay off one credit balance using another card, this generally isn’t possible. Banks don’t allow you to pay your credit card balance using another credit card. Typically, pay
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Fate Therapeutics (FATE – Research
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE